Embodiments disclosed herein relate to devices and methods for monitoring one or more physiological parameters of a subject. In an embodiment, a wearable device comprises a substrate configured to attached to a subject's skin. The substrate comprises a middle portion arranged between two end portions, wherein the middle portion is more flexible than at least one of the end portions. The wearable device also comprises a physiological sensor arranged on the middle portion. The physiological sensor is configured to sense a physiological signal of the subject when the wearable device is attached to the subject's skin. And, the wearable device comprises one or more electrical components arranged on at least one of the end portions, wherein at least one of the one or more electrical components is coupled to the physiological sensor.

A method for uterine activity monitoring may include: acquiring a plurality of signals from a plurality of sensors during uterine activity; processing the plurality of signals to extract a plurality of uterine electrical activity characteristics; analyzing the plurality of uterine electrical activity characteristics; and classifying the uterine activity as one of: a preterm labor contraction, a labor contraction, a Braxton-Hicks contraction, and a state of no contraction. A method of assessing over time a pre-term birth risk of a pregnant female may include: calculating a baseline pre-term birth risk score based on a user input; acquiring, over time, a signal from a sensor; analyzing the signal to extract a parameter of interest, such that the parameter of interest comprises a physiological parameter; and calculating an instant pre-term birth risk score based, at least in part, on the parameter of interest and the user input.

The present invention relates to a method of a method of measuring a human body analyte concentration in an interstitial fluid, comprising the step of measuring a first electrical current I.sub.1 between a working electrode and a pseudo-reference electrode while applying a first potential between the working electrode and the pseudo-reference electrode, the first potential being less than a threshold potential, the magnitude of the first electrical current being greater than the magnitude of a predetermined first threshold current, and further measuring an output electrical current between the working electrode and the pseudo-reference electrode while applying a second electrical potential, the second electrical potential being greater than the first electrical potential.

A device for measuring the turbidity of cerebrospinal fluid includes, a source of a light signal comprising having one or more wavelength(s), such that at least part of the emitted light signal passes through the cerebrospinal fluid; a flow element including an inlet and an outlet, the flow element being suitable for allowing cerebrospinal fluid to flow between the inlet and the outlet; an opaque element, arranged to absorb at least part of the emitted light signal after it has passed through the cerebrospinal fluid, and to allow another part of the emitted light signal to be reflected after it has passed through the cerebrospinal fluid; and an optical detector configured to detect the light signal after it has passed through the cerebrospinal fluid.

Several embodiments and methods are described for draining a lymphatic system for therapeutic purposes. The lymphatic draining can be performed by removal of fluid from the lymphatic system via a needle, a catheter, an access port, a reservoir, a shunt, or a combination of these devices. The drainage devices can be configured for use during only a single procedure or for reoccurring procedures.

The present invention relates to a non-invasive blood glucose measuring apparatus, for measuring the glucose level in an object of measurement, comprising: (a) an irradiation source, for irradiating a narrow-band wavelength light into said object of measurement containing a blood vessel; (b) an optical detector, for collecting and processing some of the light, irradiated by said irradiating source, which is back-scattered from the object of measurement, (c) sampling means, for sampling said orthogonally polarized beams, provided by said detector-amplifiers, for converting the data of said orthogonally polarized beams into digital codes; and (d) a computing unit, wherein said computing unit comprises an adaptive filter for enhancing the cardiac pulse pulsatile waveform, and wherein said computing unit computes the glucose level, in said object of measurement, by averaging of said sampled codes.

The present disclosure relates to a method for calculating the calibration sensitivity of a sensor for insertion into the body and, more particularly, to a method for calculating calibration sensitivity, wherein a biometric value of a user can be accurately calibrated by overcoming an error in a biometric value measured through a sensor for insertion into the body, or an error in a reference biometric value measured through a biometric information measurement device, by storing past sensitivities and using at least one of the past sensitivities and a currently calculated sensitivity to calculate a calibration sensitivity of the sensor for insertion into the body, and the calibration sensitivity of the sensor for insertion into the body can be accurately calculated, even if there is an error in the reference biometric value or the reference biometric value temporarily deviates from the range of normal biometric values of the user, by determining whether the reference biometric value used to calculate the calibration sensitivity is within an allowable range.

Some embodiments described herein relate to a method that includes receiving an optical emission signal from a sensor disposed in a vessel. The vessel can be configured for an in vitro biological process (e.g., a bioreactor), and the emission signal can be received while the sensor is in contact with a biological matrix. The emission signal can be received by a reader that is disposed outside the vessel. At least one of a presence, quantity, or concentration of an analyte can be determined based on the emission signal. Similarly stated, the emission signal emitted by the sensor can be dependent on at least one of a presence, quantity, or concentration of the analyte. In some embodiments, the emission signal can be an optical signal emitted by a sensor in response to the sensor being excited by an excitation optical signal emitted by, for example, the reader.

An apparatus comprises a diffuser, a connection tube section forming a tubular fluid passage, a first indicating element section that indicates a measurement related to a body fluid disposed between a distal end and the connection tube section, a second indicating element section that indicates that the first indicating element section is suitable for use, and a housing having a generally tubular body. The diffuser is at least partially disposed in the generally tubular body. A fluid chamber adapted to receive fluid is cooperatively defined by the housing and the diffuser. The first indicating element section is visibly disposed in a first section of the housing. The second indicating element section is disposed within the fluid chamber. A micro-needle collector to draw the fluid from a source to the distal end is attachable to the distal end.

One or more insertion mechanisms may be configured to insert and retract one or more needles associated with a component configured to implantable component into the tissue of a patient. For example, a component or implantable component may include a cannula for delivery of medication to a patient or an analyte sensor. An insertion mechanism may be configured to be part of or enclosed within a structure of the Disease Management System. For example, an insertion mechanism may be configured to operate within the structure of the Disease Management System and not require outside components or devices to apply one or more needles or implantable components to the patient.